Abnormal movement in Hong Kong stocks | Meinian Onehealth Eye (06622.HK) surges over 8% as the experimental application for cyclosporine eye gel receives FDA approval.

According to the AI Financial APP, Visionsky Technology-B (06622.HK) surged more than 8%, at the time of publication, it rose 8.47% to 3.2 Hong Kong dollars, with a turnover of 6.6874 million Hong Kong dollars.